A detailed history of Rock Springs Capital Management LP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 80,000 shares of APLS stock, worth $2.67 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
80,000
Previous 140,700 43.14%
Holding current value
$2.67 Million
Previous $5.4 Million 57.25%
% of portfolio
0.08%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$28.84 - $41.15 $1.75 Million - $2.5 Million
-60,700 Reduced 43.14%
80,000 $2.31 Million
Q2 2024

Aug 14, 2024

BUY
$38.07 - $59.71 $5.36 Million - $8.4 Million
140,700 New
140,700 $5.4 Million
Q4 2021

Feb 14, 2022

SELL
$30.74 - $49.16 $813,318 - $1.3 Million
-26,458 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$31.4 - $69.84 $830,781 - $1.85 Million
26,458 New
26,458 $872,000

Others Institutions Holding APLS

About Apellis Pharmaceuticals, Inc.


  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.66B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.